Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Infectious Disorders Drug Targets|September 30, 2021
COVID-19 in Pediatrics: A Systematic Review of Current Knowledge and PracticeEsmaeil Mehraeen, Shahram Oliaei, SeyedAhmad SeyedAlinaghi, et al.
Biomedicines|August 26, 2022
Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic StrokeAsma W Al-Thomali, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.
The Journal of Biological Chemistry|July 19, 2003
Critical amino acid residues determine the binding affinity and the Ca2+ release efficacy of maurocalcine in skeletal muscle cellsEric Estève, Sophia Smida-Rezgui, Sandor Sarkozi, et al.
Health Science Reports|February 28, 2022
Impact of COVID-19 pandemic on routine vaccination coverage of children and adolescents: A systematic reviewSeyedAhmad SeyedAlinaghi, Amirali Karimi, Hengameh Mojdeganlou, et al.
Scientific Reports|April 12, 2023
Long COVID and risk of erectile dysfunction in recovered patients from mild to moderate COVID-19Hayder M Al-Kuraishy, Ali I Al-Gareeb, Sumaiah J Alarfaj, et al.
The Journal of Biological Chemistry|June 5, 2003
A maurotoxin with constrained standard disulfide bridging: innovative strategy of chemical synthesis, pharmacology, and docking on K+ channelsSarrah M'Barek, Ignacio Lopez-Gonzalez, Nicolas Andreotti, et al.
Pakistan Journal of Pharmaceutical Sciences|April 8, 2018
Lethal toxic Dose (i.p LD50), total protein contents and comparative hemolytic potential of (99mTc labeled & non-labeled) Naja naja karachiensis venomMuhammad Hassham Bin Asad, Arooj Fatima Asad, Sumbal Bibi, et al.
Current Hypertension Reports|November 7, 2022
Hypoxia-Inducible Factor 1 and Preeclampsia: A New PerspectiveSarah M Albogami, Hayder M Al-Kuraishy, Thabat J Al-Maiahy, et al.
Pageof 15